BioAdaptives Inc (BDPT)

[Photfan]

LAS VEGAS, July 9, 2014 /PRNewswire/ -- BioAdaptives, Inc.(OTC BB: BDPT) announced that it is cleared by FINRA for quotation on OTC Bulletin Board and OTC Link under the symbol BDPT effective as of July 8, 2014. The company's market maker is awaiting approval from The Depository Trust & Clearing Corporation (DTCC) for DTC eligibility. A total of 2,000,419 shares are eligible for free trading, as noted within the Form S-1 filing, and has been dispersed to shareholders of HEMP, Inc. (Pink Sheets: HEMP) in a stock distribution.

Gerald Epling, President and Chief Executive Officer of BioAdaptives, Inc., said, "We are on-track in becoming a trading public company. News of our clearance and ticker symbol was a big step in that direction. BioAdaptives™ is working towards expanding its business. We are committed to bringing high quality nutraceuticals to market for health and wellness conscious consumers."

About BioAdaptives, Inc.

BioAdaptives, Inc. is a fully-reporting public company trading on the OTC Bulletin Board under the symbol BDPT. The company is engaged in research, development, and educational activities. The company's focus is developing products to improve health and wellness. These products include nutritional supplements and proprietary methods of optimizing the bioelectromagnetic availability of foods and beverages. For more information on BioAdaptives, Inc. please visit www.bioadaptives.com.